SIGLEC12 and renal carcinoma: In addition, SIGLEC12 is highly expressed in renal cancer and is linked to primary tumor growth, increased immune cell infiltration in the tumor microenvironment, and poor survival in kidney renal clear cell carcinoma and kidney renal papillary cell carcinoma [27].